Awakn Life Sciences is an ecosystem for psychedelic-based treatments.
Awakn Life Sciences has raised $535K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in December 2024.
Awakn Life Sciences's investors include Innovate UK, Negev Capital, National Institute for Health and Care Research, Mystic Ventures, TD Veen.
Awakn Life Sciences is headquartered in Toronto, Canada.
Awakn Life Sciences is an ecosystem for psychedelic-based treatments.
Awakn Life Sciences is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Awakn Life Sciences — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/awakn-life-sciences. Accessed August 14, 2026.
VCBacked. (2024). Awakn Life Sciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/awakn-life-sciences
{{cite web |title=Awakn Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/awakn-life-sciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated